Inzy stock price target
Web5 uur geleden · Inozyme Pharma, Inc. (Nasdaq: INZY), a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of pathologic mineralization and intimal proliferation ... WebWebull offers INZY Ent Holdg (INZY) historical stock prices, in-depth market analysis, NASDAQ: INZY real-time stock quote data, in-depth charts, free INZY options chain …
Inzy stock price target
Did you know?
WebNSD:INZY Detailed Stock Analysis, Stock Price Forecasts, Analyst Ratings, Financial Analysis, Stock News & Historic Quotes. About Us Pricing ... Quickly zoom in on the stocks with highest and lowest potential based on analyst recommendations and Stock Target Advisor's own analysis ... Web2 aug. 2024 · For Inozyme Pharma stock forecast for 2024, 11 predictions are offered for each month of 2024 with average Inozyme Pharma stock forecast of $2.01, a high …
Web3 apr. 2024 · #usa #stock #inzy@satyajitdasgupta-----🔔PLEASE LIKE, SHARE & SUBSCRIBE THE CHANNEL-----... WebBased on analysts offering 12 month price targets for INZY in the last 3 months. The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 .
Web14 apr. 2024 · The average 12-month price objective among brokerages that have covered the stock in the last year is $83.00. A number of research analysts have recently commented on the stock. Wells Fargo & Company reduced their target price on shares of UMB Financial from $95.00 to $85.00 and set an “equal weight” rating on the stock in a … Web21 sep. 2024 · View the latest Inozyme Pharma Inc. (INZY) stock price, news, historical charts, analyst ratings and financial information from WSJ.
WebStock analysis for Inozyme Pharma Inc (INZY:NASDAQ GS) including stock price, stock chart, company news, key statistics, fundamentals and company profile.
WebPrice target is the value of securities that calculate and project for the future. These prices are the views of stock analysts regarding the performance of companies in the coming days based of their past and present condition. solve with viaWebCurrently 13 wall-street analysts regularly analyze the financials of INOZYME PHARMA INC on a frequent basis to provide recommendations along with target share price. 13 … solve with distributive propertyWeb11 apr. 2024 · Inozyme Pharma, Inc. INZY is a clinical-stage rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases impacting the vasculature, soft tissue, and skeleton. solve with humanityWebView the real-time Inozyme Pharma Inc (NASDAQ INZY) share price. Assess historical data, charts, technical analysis and contribute in the forum. solve with matricesWeb13 apr. 2024 · About INZY Financial Performance Analyst Forecast According to 13 analysts, the average rating for INZY stock is "Buy." The 12-month stock price forecast … solve with quadratic formula calculatorWeb28 mrt. 2024 · Inozyme Pharma (Nasdaq:INZY) earnings and revenue forecasts, price targets ... earnings and revenue forecasts, price targets, future return on equity. … small bumps on upper arms in kidsWeb9 apr. 2024 · 4 brokers have issued twelve-month price targets for Inozyme Pharma's shares. Their INZY share price forecasts range from $6.00 to $23.00. On average, they … solve with quadratic formula